Ingenuity Systems Announces Significant Global Uptake of Variant Analysis Solution for Next-Generation Sequencing

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Ingenuity® Systems, a QIAGEN company (Nasdaq: QGEN, Frankfurt QIA) and a leading provider of biomedical information and analysis solutions, today announced that to date more than 2,500 users representing over 1,000 leading institutions worldwide – including Queen Mary, University of London and Rigshospitalet Copenhagen – have adopted the Ingenuity Variant Analysis™ web-based solution.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC